Geode Capital Management, LLC Sab Biotherapeutics, Inc. Transaction History

Geode Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.47 - $0.9 $26,242 - $50,251	55,835 Added 18.58%	356,364 $224,000
Q4 2022 Feb 13, 2023	SELL	$0.54 - $9.8 $8,712 - $158,113	-16,134 Reduced 5.1%	300,529 $177,000
Q2 2022 Aug 12, 2022	BUY	$1.11 - $3.46 $17,263 - $53,813	15,553 Added 5.17%	316,663 $459,000
Q1 2022 May 13, 2022	BUY	$1.78 - $8.5 $13,713 - $65,484	7,704 Added 2.63%	301,110 $1.13 Million
Q4 2021 Feb 11, 2022	BUY	$7.3 - $11.24 $2.14 Million - $3.3 Million	293,406 New	293,406 $2.29 Million

529K

Ticker SABS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,030,900
Market Cap $111M
Description
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.